P A Bacon

Active 1974–2013

Also published as
P. A. Bacon
70
Papers
18,307
Citations
68
h-index
70
i10-index

Citations

Citations per year for P A Bacon1974: 1 citations1976: 1 citations1978: 1 citations1979: 6 citations1980: 6 citations1981: 4 citations1982: 5 citations1983: 7 citations1984: 13 citations1985: 23 citations1986: 24 citations1987: 28 citations1988: 25 citations1989: 24 citations1990: 42 citations1991: 52 citations1992: 42 citations1993: 15 citations1994: 38 citations1995: 75 citations1996: 80 citations1997: 97 citations1998: 93 citations1999: 108 citations2000: 111 citations2001: 109 citations2002: 117 citations2003: 137 citations2004: 128 citations2005: 167 citations2006: 166 citations2007: 146 citations2008: 137 citations2009: 144 citations2010: 171 citations2011: 137 citations2012: 99 citations2013: 121 citations2014: 108 citations2015: 94 citations2016: 72 citations2017: 77 citations2018: 50 citations2019: 201 citations2020: 194 citations2021: 171 citations2022: 127 citations2023: 82 citations2024: 125 citations2025: 50 citations2026: 3 citations1975: no citations, so this year is not shown1977: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,067 citing papers, 20.6% of this breakdownUnited Kingdom: 750 citing papers, 14.5% of this breakdownFrance: 309 citing papers, 6% of this breakdownGermany: 292 citing papers, 5.6% of this breakdownItaly: 287 citing papers, 5.6% of this breakdownNetherlands: 241 citing papers, 4.7% of this breakdownCanada: 230 citing papers, 4.5% of this breakdownChina: 180 citing papers, 3.5% of this breakdownJapan: 151 citing papers, 2.9% of this breakdownSweden: 147 citing papers, 2.8% of this breakdownSpain: 140 citing papers, 2.7% of this breakdownAustralia: 110 citing papers, 2.1% of this breakdown
0%20.6%Other 24.5%

Fields

  • Medicine85.5%
  • Immunology and Microbiology5.7%
  • Biochemistry, Genetics and Molecular Biology5.6%
  • Neuroscience0.7%
  • Nursing0.7%
  • Pharmacology, Toxicology and Pharmaceutics0.4%
  • Other1.4%

Topics

  • Vasculitis and related conditions12.7%
  • Systemic Lupus Erythematosus Research8.1%
  • Rheumatoid Arthritis Research and Therapies5.8%
  • Systemic Sclerosis and Related Diseases5.4%
  • Otitis Media and Relapsing Polychondritis2.9%
  • Renal Diseases and Glomerulopathies2%
  • Other63.1%

Coauthors

All papers

Open in search
  1. Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitides

    Authors: , , , , , , - Arthritis & Rheumatism 1997 cited by 614

  2. Nomenclature of Systemic Vasculitides

    Authors: , , , , , , , , , , , , , , , - Arthritis & Rheumatism 1994 cited by 3,850

  3. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody–associated vasculitis

    Authors: , , , , , , , , - Arthritis & Rheumatism 2005 cited by 796

  4. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis

    Authors: , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2006 cited by 643

  5. The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison.

    Authors: , , , , , , , , , , , , - 2000 cited by 478

  6. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.

    Authors: , , , , , , , - 1994 cited by 1,063

  7. Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010)

    Authors: , , , , , , , , - Lara D. Veeken 2013 cited by 340

  8. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus

    Authors: , , , , , , , , - QJM 1993 cited by 566

  9. Significance of the hydrogen ion concentration in synovial fluid in rheumatoid arthritis.

    Authors: , , , , - 1985 cited by 119

  10. Development of comprehensive disease assessment in systemic vasculitis

    Authors: , , , , , , , - Postgraduate Medical Journal 2006 cited by 177

  11. A disease severity scale for systemic sclerosis: development and testing.

    Authors: , , , , , , , , , , , , , , , , - 1999 cited by 445

  12. The prevalence and incidence of systemic lupus erythematosus in Birmingham, England

    Authors: , , , - Arthritis & Rheumatism 1995 cited by 386

  13. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus.

    Authors: , , , , , , - 1997 cited by 214

  14. Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus. Members of the British Isles Lupus Assessment Group (BILAG).

    Authors: , , , , , , , , - 1988 cited by 143

  15. Quantitation of thermography in arthritis using multi-isothermal analysis. I. The thermographic index.

    Authors: , , , - Annals of the Rheumatic Diseases 1974 cited by 131

  16. HUMAN PARVOVIRUS ARTHROPATHY

    Authors: , , , , , - The Lancet 1985 cited by 458

  17. Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , H. G. Prentice, C Black, Alan Tyndall - Annals of the Rheumatic Diseases 2001 cited by 285

  18. The Spectrum of Wegener's Granulomatosis and Disease Relapse

    Authors: - New England Journal of Medicine 2005 cited by 132

  19. Natural course of penicillamine nephropathy: a long term study of 33 patients

    Authors: , , , , , , - BMJ 1988 cited by 95

  20. Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis

    Authors: , - The American Journal of Medicine 1984 cited by 259

  21. Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , A Marmont, A M Martinez, H Pascual Cascon, C Bocelli-Tyndall, E Gluckman, A Gratwohl, A Tyndall - Annals of the Rheumatic Diseases 2004 cited by 250

  22. INTRA-ARTICULAR STEROIDS IN OSTEOARTHRITIS

    Authors: , , , , - Lara D. Veeken 1980 cited by 193

  23. Suppression of Inflammation in Primary Systemic Vasculitis Restores Vascular Endothelial Function: Lessons for Atherosclerotic Disease?

    Authors: , , , , , , , - Circulation 2000 cited by 152

  24. 10 Disease assessment and management of the vasculitides

    Authors: , , , - Baillière s Clinical Rheumatology 1997 cited by 117